Latest News
Feature
Verma unveils Medicaid scorecard but refuses to judge efforts
In a meeting with reporters, Ms. Verma refused to discuss the findings in any detail or comment on any individual states that performed poorly or...
News
FDA approves first biosimilar to pegfilgrastim
The biosimilar decreases the chance of infection in patients with nonmyeloid cancer who are at risk of febrile neutropenia because of...
Feature
AMA: Opioid prescriptions down since 2013
Number of providers registered for prescription drug monitoring programs has tripled since 2014.
From the Journals
Checkpoint inhibitor shows promise in advanced squamous-cell carcinoma
The PD-1 inhibitor cemiplimab has shown a response rate in about half of patients with advanced or metastatic cutaneous squamous-cell carcinoma....
Latest News
MRD-negative status signals better outcomes in CAR T–treated ALL
CHICAGO – The study sheds light on the value of transplant after treatment with CAR T cells.
Conference Coverage
Dr. William J. Gradishar shares breast cancer take-aways from ASCO 2018
CHICAGO – TAILORx is a “big win,” while SANDPIPER results are nothing to get excited about.
From the Journals
Metastatic lung cancer: Pembrolizumab plus chemo prolongs survival
Overall survival at 12 months in NSCLC patients treated with pembrolizumab-combination therapy was 69.2%, compared with 49.4% in patients treated...
Latest News
Geriatric assessments improve oncologist-patient communications
CHICAGO – A randomized study of community oncology centers showed that when oncologists were informed of geriatric assessment results, patient...
From the Journals
Trachelectomy rate for early-stage cervical cancer rises to 17% in younger women
More young women with early-stage cervical cancer are opting for fertility-sparing trachelectomy, with similar outcomes to hysterectomy.
Conference Coverage
Pembrolizumab monotherapy shows activity in advanced recurrent ovarian cancer
CHICAGO – Antitumor activity appears strongest in patients with higher PD-L1 expression in their tumors.
Conference Coverage
Prostate cancer risk before age 55 higher for black men
SAN FRANCISCO – Efforts at identifying prostate cancer at an earlier age should consider black men as a high risk group.